AEON
Price
$0.76
Change
-$0.01 (-1.30%)
Updated
Sep 5 closing price
Capitalization
8.94M
DAWN
Price
$7.55
Change
+$0.14 (+1.89%)
Updated
Sep 5 closing price
Capitalization
773.36M
65 days until earnings call
Interact to see
Advertisement

AEON vs DAWN

Header iconAEON vs DAWN Comparison
Open Charts AEON vs DAWNBanner chart's image
AEON Biopharma
Price$0.76
Change-$0.01 (-1.30%)
Volume$83.56K
Capitalization8.94M
Day One Biopharmaceuticals
Price$7.55
Change+$0.14 (+1.89%)
Volume$899.78K
Capitalization773.36M
AEON vs DAWN Comparison Chart in %
Loading...
AEON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AEON vs. DAWN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEON is a Hold and DAWN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AEON: $0.76 vs. DAWN: $7.55)
Brand notoriety: AEON and DAWN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AEON: 79% vs. DAWN: 56%
Market capitalization -- AEON: $8.94M vs. DAWN: $773.36M
AEON [@Biotechnology] is valued at $8.94M. DAWN’s [@Biotechnology] market capitalization is $773.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEON’s FA Score shows that 1 FA rating(s) are green whileDAWN’s FA Score has 1 green FA rating(s).

  • AEON’s FA Score: 1 green, 4 red.
  • DAWN’s FA Score: 1 green, 4 red.
According to our system of comparison, AEON is a better buy in the long-term than DAWN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEON’s TA Score shows that 4 TA indicator(s) are bullish while DAWN’s TA Score has 6 bullish TA indicator(s).

  • AEON’s TA Score: 4 bullish, 4 bearish.
  • DAWN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than AEON.

Price Growth

AEON (@Biotechnology) experienced а +4.29% price change this week, while DAWN (@Biotechnology) price change was +0.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

DAWN is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DAWN($773M) has a higher market cap than AEON($8.94M). DAWN YTD gains are higher at: -40.410 vs. AEON (-98.037). AEON has higher annual earnings (EBITDA): -17.87M vs. DAWN (-108.37M). DAWN has more cash in the bank: 453M vs. AEON (8.44M). DAWN has less debt than AEON: DAWN (3M) vs AEON (16.4M). DAWN has higher revenues than AEON: DAWN (188M) vs AEON (0).
AEONDAWNAEON / DAWN
Capitalization8.94M773M1%
EBITDA-17.87M-108.37M16%
Gain YTD-98.037-40.410243%
P/E Ratio0.00N/A-
Revenue0188M-
Total Cash8.44M453M2%
Total Debt16.4M3M546%
TECHNICAL ANALYSIS
Technical Analysis
AEONDAWN
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
37%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
40%
Bullish Trend 2 days ago
66%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
39%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 11 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 5 days ago
81%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
AEON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XNCR8.550.18
+2.15%
Xencor
MKC70.910.78
+1.11%
McCormick & Company
TDW57.730.53
+0.93%
Tidewater
BQ3.02-0.01
-0.17%
Boqii Holding Limited
RCEL4.26-0.03
-0.70%
Avita Medical

AEON and

Correlation & Price change

A.I.dvisor tells us that AEON and GERN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AEON and GERN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEON
1D Price
Change %
AEON100%
-0.60%
GERN - AEON
29%
Poorly correlated
+1.45%
BLRX - AEON
28%
Poorly correlated
+3.38%
DAWN - AEON
25%
Poorly correlated
+1.89%
THRD - AEON
23%
Poorly correlated
N/A
MRSN - AEON
22%
Poorly correlated
-4.21%
More

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
+1.89%
DNLI - DAWN
49%
Loosely correlated
+4.33%
RVMD - DAWN
49%
Loosely correlated
+3.98%
SYRE - DAWN
49%
Loosely correlated
+0.06%
NRIX - DAWN
48%
Loosely correlated
+8.66%
IDYA - DAWN
48%
Loosely correlated
+5.15%
More